Evidence that abnormally large seasonal declines in vitamin D status may trigger SLE flare in non-African Americans

Lupus

Volumn 21, Issue 8, 2012, Pages 855-864

  Birmingham, D J ^a   Hebert, L A ^a   Song, H ^a   Noonan, W T ^b   Rovin, B H ^a   Nagaraja, H N ^c   Yu, C Y ^d  

^a OHIO STATE UNIVERSITY   (United States)

^b ABBOTT LABORATORIES   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

disease flare; systemic lupus erythematosus; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; ETHNICITY; EUROPEAN AMERICAN; FEMALE; FOLLOW UP; HISPANIC; HUMAN; LONGITUDINAL STUDY; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; RELAPSE; SEASON; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AFRICAN AMERICANS; ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LONGITUDINAL STUDIES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; SEASONS; SEVERITY OF ILLNESS INDEX; SUNLIGHT; TIME FACTORS; VITAMIN D;

EID: 84861812299     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203312439640     Document Type: Article

References (54)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007 ; 357: 266-281
2. Rosen CJ. Clinical practice. Vitamin D insufficiency. N Engl J Med. 2011 ; 364: 248-254
3. Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation. 2007 ; 115: 846-854
4. Swales HH, Wang TJ. Vitamin D and cardiovascular disease risk: emerging evidence. Curr Opin Cardiol 2010; 25: 513-517.
5. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: a systematic review. Nat Rev Cardiol. 2009 ; 6: 621-630
6. Noonan W, Koch K, Nakane M, et al. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats. Nephrol Dial Transplant. 2008 ; 23: 3824-3830
7. Freedman BI, Wagenknecht LE, Hairston KG, et al. Vitamin d, adiposity, and calcified atherosclerotic plaque in african-americans. J Clin Endocrinol Metab. 2010 ; 95: 1076-1083
8. Razzaque MS. The dualistic role of vitamin D in vascular calcifications. Kidney Int. 2011 ; 79: 708-714
9. Kovesdy CP, Kalantar-Zadeh K. Vitamin D receptor activation and survival in chronic kidney disease. Kidney Int. 2008 ; 73: 1355-1363
10. Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med. 2008 ; 168: 1629-1637
11. Shoben AB, Rudser KD, de Boer IH, Young B, Kestenbaum B. Association of oral calcitriol with improved survival in nondialyzed CKD. J Am Soc Nephrol. 2008 ; 19: 1613-1619
12. Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med. 2008 ; 168: 1340-1349
13. Wu J, Garami M, Cheng T, Gardner DG. 1,25(OH)2 vitamin D3, and retinoic acid antagonize endothelin-stimulated hypertrophy of neonatal rat cardiac myocytes. J Clin Invest. 1996 ; 97: 1577-1588
14. Li YC, Qiao G, Uskokovic M, Xiang W, Zheng W, Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004 ; 89-90: 387-392
15. Freundlich M, Quiroz Y, Zhang Z, et al. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int. 2008 ; 74: 1394-1402
16. Zhang Z, Zhang Y, Ning G, Deb DK, Kong J, Li YC. Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase. Proc Natl Acad Sci U S A. 2008 ; 105: 15896-15901
17. Hypponen E, Boucher BJ, Berry DJ, Power C. 25-hydroxyvitamin D, IGF-1, and metabolic syndrome at 45 years of age: a cross-sectional study in the 1958 British Birth Cohort. Diabetes. 2008 ; 57: 298-305
18. Patel NM, Gutierrez OM, Andress DL, Coyne DW, Levin A, Wolf M. Vitamin D deficiency and anemia in early chronic kidney disease. Kidney Int. 2010 ; 77: 715-720
19. Agarwal R, Acharya M, Tian J, et al. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int. 2005 ; 68: 2823-2828
20. Zhang Z, Yuan W, Sun L, et al. 1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells. Kidney Int. 2007 ; 72: 193-201
21. Zehnder D, Quinkler M, Eardley KS, et al. Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation. Kidney Int. 2008 ; 74: 1343-1353
22. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 2011 ; 57: 63-69
23. Agmon-Levin N, Blank M, Zandman-Goddard G, et al. Vitamin D: an instrumental factor in the anti-phospholipid syndrome by inhibition of tissue factor expression. Ann Rheum Dis. 2011 ; 70: 145-150
24. Nettis E, Colanardi MC, Loria MP, Vacca A. Acquired C1-inhibitor deficiency in a patient with systemic lupus erythematosus: a case report and review of the literature. Eur J Clin Invest. 2005 ; 35: 781-784
25. Dusso AS, Tokumoto M. Defective renal maintenance of the vitamin D endocrine system impairs vitamin D renoprotection: a downward spiral in kidney disease. Kidney Int. 2011 ; 79: 715-729
26. Baeke F, Gysemans C, Korf H, Mathieu C. Vitamin D insufficiency: implications for the immune system. Pediatr Nephrol 2010; 10: 482-496.
27. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010 ; 10: 482-496
28. Bijl M, Kallenberg CG. Ultraviolet light and cutaneous lupus. Lupus. 2006 ; 15: 724-727
29. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O'Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001 ; 167: 4974-4980
30. Rausch-Fan X, Leutmezer F, Willheim M, et al. Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int Arch Allergy Immunol. 2002 ; 128: 33-41
31. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1alpha,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A. 2001 ; 98: 6800-6805
32. Chen S, Sims GP, Chen XX, Gu YY, Lipsky PE. Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol. 2007 ; 179: 1634-1647
33. Kamen D, Aranow C. The link between vitamin D deficiency and sytemic lupus erythematosus. Curr Rheumatol Rep. 2008 ; 10: 273-280
34. Mok CC, Birmingham DJ, Leung HW, Hebert LA, Song H, Rovin BH. Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology 2011 published on 29 June 29 2011 doi:101093/rheumatology/ker212.
35. Lewis E, Hunsicker L, Lan S-P, Rohde R, Lachin J, the Lupus Nephritis Collaborative Study Group, including , Hebert LA. A controlled trial of plasmapheresis therapy in severe lupus nephritis. N Engl J Med. 1992 ; 326: 1373-1379
36. Hay EM, Bacon PA, Gordon C, et al. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med. 1993 ; 86: 447-458
37. Alarcon-Segovia D, Tumlin JA, Furie RA, et al. LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2003 ; 48: 442-454
38. Rovin BH, Tang Y, Sun J, et al. Clinical significance of fever in the SLE patient receiving steroid therapy. Kidney Int. 2005 ; 68: 747-759
39. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol. 2005 ; 16: 467-473
40. Birmingham DJ, Nagaraja HN, Rovin BH, et al. Fluctuation in self-perceived stress and increased risk of flare in patients with lupus nephritis carrying the serotonin receptor 1A -1019 G allele. Arthritis Rheum. 2006 ; 54: 3291-3299
41. Maxwell JD. Seasonal variation in vitamin D. Proc Nutr Soc. 1994 ; 53: 533-543
42. Birmingham D, Rovin B, Shidham G, Bissell M, Nagaraja H, Hebert L. Relationship between albuminuria and total proteinuria in SLE nephritis: diagnostic and therapeutic implication. Clin J Am Soc Nephrol. 2008 ; 3: 1028-1033
43. Shoenfeld N, Amital H, Shoenfeld Y. The effect of melanism and vitamin D synthesis on the incidence of autoimmune disease. Nat Clin Pract Rheumatol. 2009 ; 5: 99-105
44. Kamen D, Aranow C. Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol. 2008 ; 20: 532-537
45. Albert PJ, Proal AD, Marshall TG. Vitamin D: the alternative hypothesis. Autoimmun Rev. 2009 ; 8: 639-644
46. Adams JS, Sharma OP, Gacad MA, Singer FR. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest. 1983 ; 72: 1856-1860
47. Fritsche J, Mondal K, Ehrnsperger A, Andreesen R, Kreutz M. Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells. Blood. 2003 ; 102: 3314-3316
48. Webb AR, Kline L, Holick MF. Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab. 1988 ; 67: 373-378
49. Harris SS. Vitamin D and African Americans. J Nutr. 2006 ; 136: 1126-1129
50. Harris SS, Dawson-Hughes B. Seasonal changes in plasma 25-hydroxyvitamin D concentrations of young American black and white women. Am J Clin Nutr. 1998 ; 67: 1232-1236
51. Craig SM, Yu F, Curtis JR, et al. Vitamin D status and its associations with disease activity and severity in African Americans with recent-onset rheumatoid arthritis. J Rheumatol. 2010 ; 37: 275-281
52. Michos E, Reis J, Post W, et al. Vitamin D deficiency is associated with increased risk of fatal stroke among whites but not blacks: the NHANES II linked mortality files [Abstract]. Circulation. 2010 ; 122: A9478 - A9478
53. Alarcon GS, Roseman J, Bartolucci AA, et al. Systemic lupus erythematosus in three ethnic groups: II. Features predictive of disease activity early in its course. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998 ; 41: 1173-1180
54. Alarcon GS, Friedman AW, Straaton KV, et al. Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs. Nurture. Lupus. 1999 ; 8: 197-209